New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...
Key Milestone Builds Toward Doubling Patent Portfolio to Over 200 Worldwide – Positioning Propanc as a Long-Term Leader in Metastatic Cancer PreventionMELBOURNE, Australia, Jan. 27, 2026 (GLOBE ...
Aspire Biopharma (ASBP) announced the filing of a new provisional patent application with the United States Patent and ...
IndulgeRx’s new patent applications elevate IRX FOODSCORE™ and its Relevant Nutrition Scores (RNS) as the global ...
New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.
NatGold Digital Ltd. ("NatGold" or the "Company") today announced it has strengthened its intellectual property strategy by filing seven full (non-provisional) patent applications with the United ...
The Federal Circuit held that provisional application language omitted from the final patent cannot support broader claim interpretations. Courts may treat changes and omissions between provisional ...
Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...
The US Court of Appeals for the Federal Circuit dismissed an appeal from a patent applicant seeking provisional rights on a patent that would issue only after it had already expired, finding that the ...
As part of the effort to harmonize global patent systems, the United States introduced the provisional patent application in 1995 as part of the GATT Uruguay Round agreement. The provisional patent ...